表紙
市場調查報告書
商品編碼
1069638

肝吸蟲症治療的全球市場:各類型,各診斷手術,各症狀,各終端用戶,各地區,競爭預測和機會,2017年∼2027年

Global Opisthorchiasis Treatment Market, By Type, By Diagnostic Procedure, By Symptom, By End User, By Region, Competition Forecast and Opportunities, 2017-2027

出版日期: | 出版商: TechSci Research | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球肝吸蟲症治療的市場規模,預計在預測期間內大幅成長。

該市場的成長,起因於在世界人口之間由於肝吸蟲和貓肝吸蟲的感染疾病的發生率上升。味道和營養價值高的魚貝類需求高,在海洋動物中發現的泰國肝吸蟲造成的寄生蟲感染疾病相關的認識低,推動全球肝吸蟲症治療市場成長。

本報告提供全球肝吸蟲症治療市場相關調查,市場概要,以及各類型,診斷手術,各症狀,各終端用戶,各地區的趨勢,競爭趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 服務概要

第2章 調查手法

第3章 摘要整理

第4章 COVID-19對全球肝吸蟲症治療市場的影響

第5章 客戶的迴響

第6章 全球肝吸蟲症治療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型(投藥,手術)
    • 診斷程序(膽管造影,MRI,超音波檢驗,電腦斷層掃描,其他)
    • 各症狀(黃疸,腹瀉,發熱,脾腫,體重減少,心搏過速,其他)
    • 各終端用戶(醫院、診所,門診病人診療中心,其他)
    • 各企業(2021年)
    • 各地區
  • 市場地圖

第7章 北美的肝吸蟲症治療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 北美:各國分析

第8章 歐洲的肝吸蟲症治療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 歐洲:各國分析

第9章 亞太地區的肝吸蟲症治療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 亞太地區:各國分析

第10章 南美的肝吸蟲症治療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 南美:各國分析

第11章 中東、非洲的肝吸蟲症治療市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 中東、非洲:各國分析

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • Cipla Inc.
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd.
  • Merck KGaA
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc
  • Mankind Pharma Limited

第15章 策略性推薦事項

目錄
Product Code: 8163

The global opisthorchiasis treatment market is expected to grow at a significant rate during the forecast period. The market growth can be attributed to the rising incidences of infectious diseases caused by liver fluke and cat fluke among the global population. High demand for seafood due to their taste and nutritional value but lack of awareness about the parasitic infection caused by Opisthorchis Viverrini found in marine animals is boosting the growth of the global opisthorchiasis treatment market. Growing research and development activities for the early diagnosis and effective treatment options for diseases with advanced pharmaceutical products and surgical therapies. Prolonged infection exposure and the growing prevalence of chronic conditions in Asian countries like Thailand, Vietnam, Korea, and China are expected to fuel the growth of the global opisthorchiasis treatment market. Limited knowledge about the rules for disinfection of the local population and an increase in the number of amateur fishermen and poachers are contributing to the growing incidences of opisthorchiasis, which is propelling the growth of the global opisthorchiasis treatment market. Increasing awareness about the environmental depletion due to contamination of water sources in ocean and water bodies by untreated waste dump are further aiding to the rising infection in marine life, contributing to the growing liver infections among the global population. As people across the globe are increasingly becoming aware of the diseases and their available treatments, the demand for healthcare services and treatments is booming at an exponential rate. Moreover, the growing number of healthcare facilities, the emergence of new technologies, and rising innovation are expected to fuel the growth of the global opisthorchiasis treatment market during the forecast period.

The global opisthorchiasis treatment market is segmented on the basis on type, diagnostic procedure, symptom, end user, regional distribution, and competitive landscape. Based on diagnostic procedure, the market is divided into Cholangiography, MRI, Ultrasonography, CT scan, and others. The Cholangiography segment is expected to hold the largest share in the global opisthorchiasis treatment market due to the standardization of stool examination. Based on end-user, the market is fragmented into hospitals & clinics, ambulatory care centres, and others. The hospitals & clinics segment is anticipated to dominate the global opisthorchiasis treatment market as they provide better medical equipment, products, and services to the patients.

Major players operating in the global opisthorchiasis treatment market include Cipla Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Merck KGaA, Boehringer Ingelheim International GmbH, Pfizer Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., AbbVie Inc., Mankind Pharma Limited, among others.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global opisthorchiasis treatment market from 2017 to 2021.
  • To estimate and forecast the market size of global opisthorchiasis treatment market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast global opisthorchiasis treatment market based on type, diagnostic procedure, symtom, end user, region, and competitive landscape.
  • To identify dominant region or segment in the global opisthorchiasis treatment market.
  • To identify drivers and challenges for global opisthorchiasis treatment market.
  • To examine competitive developments such as expansions, new services, mergers & acquisitions, etc., in global opisthorchiasis treatment market.
  • To identify and analyze the profile of leading players operating in global opisthorchiasis treatment market.
  • To identify key sustainable strategies adopted by market players in global opisthorchiasis treatment market.

Report Scope:

In this report, global opisthorchiasis treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Opisthorchiasis Treatment Market, By Type:

Medications

  • Antibiotics
  • Anthelmintics
  • Others

Surgery

  • Opisthorchiasis Treatment Market, By Diagnostic Procedure:

Cholangiography

MRI

Ultrasonography

CT scan

Others

  • Opisthorchiasis Treatment Market, By Symptom:

Jaundice

Diarrhea

Fever

Splenomegaly

Weight loss

Tachycardia

Others

  • Opisthorchiasis Treatment Market, By End User:

Hospitals & Clinics

Ambulatory Care Centers

Others

  • Opisthorchiasis Treatment Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies, which could not be identified due to the limitations of secondary research. TechSci Research analyzed the companies and presence of all major players across the globe.

TechSci Research calculated the market size of the global opisthorchiasis treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these treatment types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Opisthorchiasis treatment service provider companies/partners
  • End-Users
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to global opisthorchiasis treatment market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc. besides allowing them in strategizing investments and capitalizing on market opportunities.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global opisthorchiasis treatment market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Opisthorchiasis Treatment Market

5. Voice of Customer

  • 5.1. Prevalence, By Geography
  • 5.2. Prevalence, By Gender
  • 5.3. Commonly Observed Symptoms
  • 5.4. Preferred Choice of Treatment

6. Global Opisthorchiasis Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Medications v/s Surgery)
      • 6.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
    • 6.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
    • 6.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
    • 6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Market Map

7. North America Opisthorchiasis Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Medications v/s Surgery)
      • 7.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
    • 7.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
    • 7.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
    • 7.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Opisthorchiasis Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Diagnostic Procedure
        • 7.3.1.2.3. By Symptom
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Opisthorchiasis Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Diagnostic Procedure
        • 7.3.2.2.3. By Symptom
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Opisthorchiasis Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Diagnostic Procedure
        • 7.3.3.2.3. By Symptom
        • 7.3.3.2.4. By End User

8. Europe Opisthorchiasis Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Medications v/s Surgery)
      • 8.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
    • 8.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
    • 8.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
    • 8.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Opisthorchiasis Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Diagnostic Procedure
        • 8.3.1.2.3. By Symptom
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Opisthorchiasis Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Diagnostic Procedure
        • 8.3.2.2.3. By Symptom
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Opisthorchiasis Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Diagnostic Procedure
        • 8.3.3.2.3. By Symptom
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Opisthorchiasis Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Diagnostic Procedure
        • 8.3.4.2.3. By Symptom
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Opisthorchiasis Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Diagnostic Procedure
        • 8.3.5.2.3. By Symptom
        • 8.3.5.2.4. By End User

9. Asia-Pacific Opisthorchiasis Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Medications v/s Surgery)
      • 9.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
    • 9.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
    • 9.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
    • 9.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Opisthorchiasis Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Diagnostic Procedure
        • 9.3.1.2.3. By Symptom
        • 9.3.1.2.4. By End User
    • 9.3.2. India Opisthorchiasis Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Diagnostic Procedure
        • 9.3.2.2.3. By Symptom
        • 9.3.2.2.4. By End User
    • 9.3.3. South Korea Opisthorchiasis Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Diagnostic Procedure
        • 9.3.3.2.3. By Symptom
        • 9.3.3.2.4. By End User
    • 9.3.4. Japan Opisthorchiasis Treatment Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Diagnostic Procedure
        • 9.3.4.2.3. By Symptom
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Opisthorchiasis Treatment Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Diagnostic Procedure
        • 9.3.5.2.3. By Symptom
        • 9.3.5.2.4. By End User

10. South America Opisthorchiasis Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Medications v/s Surgery)
      • 10.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
    • 10.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
    • 10.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
    • 10.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Opisthorchiasis Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Diagnostic Procedure
        • 10.3.1.2.3. By Symptom
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Opisthorchiasis Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Diagnostic Procedure
        • 10.3.2.2.3. By Symptom
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Opisthorchiasis Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Diagnostic Procedure
        • 10.3.3.2.3. By Symptom
        • 10.3.3.2.4. By End User

11. Middle East and Africa Opisthorchiasis Treatment Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Medications v/s Surgery)
      • 11.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
    • 11.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
    • 11.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
    • 11.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Opisthorchiasis Treatment Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Diagnostic Procedure
        • 11.3.1.2.3. By Symptom
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Opisthorchiasis Treatment Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Diagnostic Procedure
        • 11.3.2.2.3. By Symptom
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Opisthorchiasis Treatment Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Diagnostic Procedure
        • 11.3.3.2.3. By Symptom
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Cipla Inc.
  • 14.2. Johnson & Johnson
  • 14.3. Sun Pharmaceutical Industries Ltd.
  • 14.4. Merck KGaA
  • 14.5. Boehringer Ingelheim International GmbH
  • 14.6. Pfizer Inc.
  • 14.7. GlaxoSmithKline plc
  • 14.8. F. Hoffmann-La Roche Ltd
  • 14.9. AbbVie Inc
  • 14.10. Mankind Pharma Limited

15. Strategic Recommendations